Finch Therapeutics Group Inc

NASDAQ:FNCH   3:59:52 PM EDT
2.05
+0.02 (+0.98%)
Earnings Announcements

Finch Therapeutics Reports Fourth Quarter And Full Year 2021 Financial Results

Published: 03/31/2022 21:13 GMT
Finch Therapeutics Group Inc (FNCH) - Finch Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates.
Finch Therapeutics Group Inc - Cash and Cash Equivalents Sufficient to Fund Operating Expenses and Capital Expenditures Into Mid-2023.
Finch Therapeutics Group Inc - Qtrly Loss per Share $0.40.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.46

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.47

More details on our Analysts Page.